Effect of phosphodiesterase inhibitor on senile lung function during preservation period

YZ Wei,QY Wu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.34.005
2007-01-01
Abstract:AIM: To study the protective effect of agent milrinone, a kind of specific phosphodiesterase inhibitor, on senile grafts during graft procurement and cold preservation period. METHODS: The experiment was conducted in the Department of Surgery, Fuwai Cardiovascular Institute from October to December 2006. ①Twenty-four 20-week-old SD rats and 12 one-year-old SD rats were randomly divided into 3 groups. In control group (6 young rats as donors, and another 6 as recipients), the lungs were flushed with low potassium dextran (LPD) solution and preserved in refrigerator at 4 ℃ for 12 hours, followed by 60 minutes reperfusion at 5 mL/min. Preservation group (6 senile rats as donors and 6 young rats as recipients) was washed with corresponding solution according to their body mass, and then treated with the same method as control group. In milrinone group (6 senile rats as donors and 6 young rats as recipients), there was 666 μg/L milrinone in LPD solution and the rest was the same as group preservation group. ②The oxygen partial pressure, mean pulmonary arterial pressure (MPAP), lung airway pressure changes, ratio of lung wet weight and dry weight after reperfusion, malondialdehyde (MDA) content in lung tissue and myeloperoxidase (MPO) of donor lung in each group were observed. RESULTS: All 36 rats were involved in the result analysis. ①With the reperfusion, the oxygen partial pressure of preservation group at each stage was lower than that in control group (P < 0.05), MPAP was higher than that in control group (P < 0.05), airway pressure was higher than control group after 40 and 60 minutes reperfusion (P < 0.05). However, there was no significant difference between milrinone group and control group (P > 0.05). ②The wet/dry ratio, MDA content and MPO activity in preservation group after reperfusion were significantly higher than those in control group (P < 0.05), but no difference was found between milrinone group and control group (P > 0.05). CONCLUSION: Phosphodiesterase inhibitor milrinone protects senile grafts from ischemia/reperfusion injury and remarkably improve early lung function after pulmonary transplantation during cold storage period.
What problem does this paper attempt to address?